IPO Issue of Om Megashree Pharmaceuticals Closing Today; Oversubscribed 13.27 Times So Far

Om Megashree Pharmaceuticals Limited is closing the issue of 14,76,000 units of IPO shares at a par value of Rs 100 from today, the 3rd Chaitra, 2081. The issue opened for the general public on the 27th Falgun, 2081.

The company's issued capital is Rs. 60 Crores, of which 30%, i.e., 18,00,000 unit shares worth Rs. 18 Crores, will be issued later for the general public. Of this public issue, 10% of the shares, totaling 1,80,000 units, have already been issued for Nepalese citizens working abroad. Out of 18,00,000 units, 90,000 (i.e., 5% of 18,00,000) have been set aside for mutual funds, and 54,000 (i.e., 3% of 18,00,000) units have been set aside for the company's employees. The remaining 14,76,000 units are for the general public, the issue of which will close from today.

Prabhu Capital Limited is appointed as the issue manager. Applications can be placed for a minimum of 10 units and a maximum of 10,000 units.

According to CDSC, 16,18,978 applicants have applied for 1,96,00,430 units worth Rs. 1.96 Arba. Thus, the issue has already been oversubscribed 13.27 times.

CARE Ratings Nepal Limited (CRNL) has reaffirmed the ‘CARE-NP BB- (Is)’ rating for Om Megashree Pharmaceuticals Limited (OMPL), indicating a moderate default risk for timely financial obligations. Additionally, CRNL has reaffirmed the ‘CARE-NP BB-’ rating for OMPL’s long-term bank facilities and the ‘CARE-NP A4’ rating for its short-term bank facilities.

Om Megashree Pharmaceuticals Limited, established on June 12, 2016, is a public limited company in Nepal promoted by a group of institutional and individual investors. The company manufactures pharmaceutical products at its Chitwan-based plant and began partial operations on February 19, 2024.